AU7701100A - Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer - Google Patents

Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer

Info

Publication number
AU7701100A
AU7701100A AU77011/00A AU7701100A AU7701100A AU 7701100 A AU7701100 A AU 7701100A AU 77011/00 A AU77011/00 A AU 77011/00A AU 7701100 A AU7701100 A AU 7701100A AU 7701100 A AU7701100 A AU 7701100A
Authority
AU
Australia
Prior art keywords
kits
assessment
therapy
prevention
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77011/00A
Inventor
John Lee
James Lillie
Pamela Thompsho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
MILLENNIUM PREDICTIVE MEDICINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MILLENNIUM PREDICTIVE MEDICINE filed Critical MILLENNIUM PREDICTIVE MEDICINE
Publication of AU7701100A publication Critical patent/AU7701100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU77011/00A 1999-09-03 2000-09-01 Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer Abandoned AU7701100A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US15254799P 1999-09-03 1999-09-03
US60152547 1999-09-03
US19034700P 2000-03-16 2000-03-16
US60190347 2000-03-16
US19132100P 2000-03-21 2000-03-21
US60191321 2000-03-21
US20838200P 2000-05-31 2000-05-31
US60208382 2000-05-31
US22046700P 2000-07-20 2000-07-20
US60220467 2000-07-20
PCT/US2000/024199 WO2001018542A2 (en) 1999-09-03 2000-09-01 Identification, assessment, prevention, and therapy of ovarian cancer

Publications (1)

Publication Number Publication Date
AU7701100A true AU7701100A (en) 2001-04-10

Family

ID=27538427

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77011/00A Abandoned AU7701100A (en) 1999-09-03 2000-09-01 Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer

Country Status (2)

Country Link
AU (1) AU7701100A (en)
WO (1) WO2001018542A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7747389B2 (en) 2001-07-23 2010-06-29 F. Hoffmann-La Roche Ag Scoring system for the prediction of cancer recurrence

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962980B2 (en) 1999-09-24 2005-11-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6468546B1 (en) 1998-12-17 2002-10-22 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
US7888477B2 (en) 1998-12-17 2011-02-15 Corixa Corporation Ovarian cancer-associated antibodies and kits
US6951738B2 (en) 1999-07-16 2005-10-04 Human Genome Sciences, Inc. Human tumor necrosis factor receptors TR13 and TR14
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
US20020182619A1 (en) * 2000-11-08 2002-12-05 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
AT410673B (en) * 2001-03-22 2003-06-25 Red Bull Gmbh Detecting Alzheimer's disease and Down's syndrome, from underexpression of phosphoprotein ARPP-19, in tissue or body fluid
FR2826373A1 (en) * 2001-06-20 2002-12-27 Molecular Engines Laboratoires SEQUENCES INVOLVED IN THE PHENOMENA OF TUMOR DEPRESSION, TUMOR REVERSION APOPTOSIS AND / OR RESISTANCE TO VIRUSES AND THEIR USE AS MEDICAMENTS
US7270960B2 (en) * 2001-08-29 2007-09-18 Pacific Northwest Research Institute Diagnosis of ovarian carcinomas
ATE364690T1 (en) 2001-11-09 2007-07-15 Proteologics Inc POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS
WO2003087372A2 (en) * 2002-04-12 2003-10-23 Molecular Engines Laboratories Growth factor derived from hepatome and the use of the same
WO2005005661A2 (en) * 2003-07-02 2005-01-20 Novartis Ag Genes regulated in ovarian cancer as prognostic and therapeutic targets
US7608413B1 (en) 2005-03-25 2009-10-27 Celera Corporation Kidney disease targets and uses thereof
SG190466A1 (en) * 2011-11-18 2013-06-28 Agency Science Tech & Res Methods for diagnosis and/or prognosis of ovarian cancer
CN114702566B (en) * 2022-03-29 2023-08-01 浙江大学 Small peptide encoded by long-chain non-coding RNA LINC01234 and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242813A (en) * 1990-10-12 1993-09-07 The United States Of America As Represented By The Department Of Health And Human Services Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors
US5871941A (en) * 1995-07-28 1999-02-16 Univ British Columbia Method of testing expression of CA125 antigen in cultured ovarian surface epithelial cells to identify and monitor individuals having a predisposition to develop ovarian cancer
WO1998041656A1 (en) * 1997-03-19 1998-09-24 The Board Of Trustees Of The University Of Arkansas Compositions and method for the early diagnosis of ovarian cancer
AU6764398A (en) * 1997-03-20 1998-10-12 Variagenics, Inc. Target genes for allele-specific drugs
US5965377A (en) * 1997-03-24 1999-10-12 Baystate Medical Center Method for determining the presence of mutated BRCA protein
WO1999028471A2 (en) * 1997-12-01 1999-06-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7747389B2 (en) 2001-07-23 2010-06-29 F. Hoffmann-La Roche Ag Scoring system for the prediction of cancer recurrence
US8655597B2 (en) 2001-07-23 2014-02-18 F. Hoffmann-La Roche Ag Scoring system for the prediction of cancer recurrence

Also Published As

Publication number Publication date
WO2001018542A2 (en) 2001-03-15
WO2001018542A3 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU2002322280A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2002337657A1 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
AU2001229340A1 (en) Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU4592601A (en) Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
AU2002324451A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
AU2001241541A1 (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
AU2074201A (en) Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2001236519A1 (en) Identification, assessment, prevention, and therapy of prostate cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU7701100A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
AU2003293194A1 (en) Compositions and methods for treating prostate cancer
AU2002365166A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
AU2003230750A1 (en) Compositions and methods for treating cancer
AU2003225535A1 (en) Methods and compositions for treating cancer
AU2003226676A1 (en) Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
EP1176964B8 (en) Uses of et743 for treating cancer
AU2001251613A1 (en) Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
AU2596901A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2002241720A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
AU2074101A (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001238493A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU2001249317A1 (en) Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase